HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Sulmazole

HCID 5353
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
73384-60-8
Standard SMILES
COc1cc(S(C)=O)ccc1-c1nc2ncccc2[nH]1
InChIKey
XMFCOYRWYYXZMY-UHFFFAOYSA-N
Molecular formula
C14H13N3O2S
Average molar mass
287.34 g/mol
Monoisotopic mass
287.07284784

Overview

Sulmazole is an imidazopyridine that is 1H-imidazo[4,5-b]pyridine which is substituted at position 2 by a 2-methoxy-4-(methylsulfinyl)phenyl group. An A1 adenosine receptor antagonist, it was formerly used as a cardiotonic agent. It has a role as a cardiotonic drug, an EC 3.1.4.* (phosphoric diester hydrolase) inhibitor and an adenosine A1 receptor antagonist. It is a sulfoxide and an imidazopyridine.

Names & identifiers

Preferred name
Sulmazole
IUPAC
2-(2-methoxy-4-methylsulfinylphenyl)-1H-imidazo[4,5-b]pyridine
English name
2-[2-Methoxy-4-(methylsulfinyl)phenyl]-1H-imidazo[4,5-b]pyridine
Molecular formula
C14H13N3O2S
Molecular weight
287.34

Names & synonyms

sulmazole73384-60-8sulmazolVardaxSulmazolumDTXSID10406172-[2-methoxy-4-(methylsulfinyl)phenyl]-1H-imidazo[4,5-b]pyridineNSC-757867HK56EH9K44CHEBI:349882-(2-Methoxy-4-(methylsulfinyl)phenyl)-3H-imidazo[4,5-b]pyridineDTXCID9020617
Show more names
ar-l115bs5-b)pyridine,2-(2-methoxy-4-(methylsulfinyl)phenyl)-1h-imidazo(3H-Imidazo[4,5-b]pyridine, 2-[2-methoxy-4-(methylsulfinyl)phenyl]-
2-(2-Methoxy-4-(methylsulfinyl)phenyl)-1H-imidazo(4,5-b)pyridine2-(2-Methoxy-4-(methylsulfinyl)phenyl)-3H-imidazo(4,5-b)pyridine2-(2-Methoxy-4-[methylsulfinyl]phenyl)-1H-imidazo(4,5-b)pyridine1H-Imidazo(4,5-b)pyridine, 2-(2-methoxy-4-(methylsulfinyl)phenyl)-2-((2-methoxy-4-methylsulfinyl)phenyl)-H-imidazo(4,5-b)pyridine2-[2-methoxy-4-(methylsulfinyl)phenyl]-3H-imidazo[4,5-b]pyridineBWA746CMG-28734

Database identifiers

CAS
73384-60-8
PubChem CID
5353

Properties

Computed structural properties

XLogP
1.2
Topological polar surface area
87.1 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
5
Rotatable bonds
3
Heavy atoms
20
Formal charge
0
Complexity
368

Experimental & physicochemical properties

LogP1.17
Collision Cross Section · 2 items

166.4 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

164.58 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physicochemical properties

Melting point
203 · 203-205°
Boiling point
527.3 · 527.3±60.0 °C(Predicted)
Density
1.43 · 1.43±0.1 g/cm3(Predicted)
storage temp.
2 · 2-8°C
pka
6 · 6+-.0.20(Predicted)
FDA UNII
56 EH9K44 · HK56EH9K44
Comptox DTXSID
1040617 · DTXSID1040617
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
319 · H319-H302-H335-H315

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 39 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Hazard Classes and CategoriesAcute Tox. 4 (100%)

Safety data

wgk
3
rtecs
NJ5749500
Toxicity
LD50 in albino mice (mg/kg): 560 orally; 163 i.v. (Diederen, Kadatz)
risk_code
22-36/37/38
Signal word
Warning
Symbol(GHS)
GHS07
hazard_code
Xn
safety_code
26-36
Hazard statements
H319-H302-H335-H315
Precautionary statements
P264-P270-P301+P312-P330-P501-P264-P280-P302+P352-P321-P332+P313-P362-P264-P280-P305+P351+P338-P337+P313P

Chemistry & industry

Pharmacology

MeSH Pharmacological Classification · 2 items

Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE).

Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases.

Applications

UsesSulmazole is a cardiotonic agent. Sulmazole has competitive inhibitory for A1 adenosine receptor. Sulmazole can improve cardiac index and reduce pulmonary capillary wedge pressure[1].

Additional notes

DefinitionChEBI: An imidazopyridine that is 1H-imidazo[4,5-b]pyridine which is substituted at position 2 by a 2-methoxy-4-(methylsulfinyl)phenyl group. An A1 adenosine receptor antagonist, it was formerly used as a cardi tonic agent.

Related reactions

2 records
New reaction record
HRID 223358 reaction equation
HRID 223358As reactant
HRID 937060 reaction equation
HRID 937060As reactant

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
DTXSID
DTXSID1040617
ChEMBL
CHEMBL286020
ChEBI
CHEBI:34988
UNII
HK56EH9K44
EC Number
277-406-1
Nikkaji
J11.238K
Precautionary statements
264 · P264-P270-P301+P312-P330-P501-P264-P280-P302+P352-P321-P332+P313-P362-P264-P280-P305+P351+P338-P337+P313P
Hazard Codes
Xn
Risk Statements
22 · 22-36/37/38
Safety Statements
26 · 26-36
WGK Germany
3 · 3
RTECS
5749500 · NJ5749500
Toxicity
50 in · LD50 in albino mice (mg/kg): 560 orally; 163 i.v. (Diederen, Kadatz)